Lv11
90 积分 2024-03-07 加入
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
9小时前
已完结
Practical recommendations for using ctDNA in clinical decision making
2个月前
已完结
Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial
3个月前
已完结
皖公网安备34019202002308
